Hikma is a Global Pharmaceutical company, engaged in development, manufacturing and marketing of generics and in-licensed pharmaceuticals. Excels in MENA, Europe and USA markets, and on the lookout for acquisitions and expansion opportunities.

Operations structured in three Business Units: Injectables, Generics and Branded Generics. Manufacturing operations established among 15 manufacturing sites in MENA, Western Europe and USA all 100% owned by Hikma.